Systemic risk profiles of topical ruxolitinib and oral Janus kinase inhibitors in patients with atopic dermatitis: A retrospective cohort study from the TriNetX network
- Journal:
- Journal of the American Academy of Dermatology
- Published:
- Affiliations:
- 2
- Authors:
- 4
| Institutions | Authors | Share |
|---|---|---|
| University of Texas Medical Branch (UTMB), United States of America (USA) | 1.00 |